已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
开喉剑如锋应助汤317采纳,获得10
1秒前
1秒前
1秒前
路漫漫其修远兮完成签到 ,获得积分10
2秒前
4秒前
丘比特应助谦让水池采纳,获得30
5秒前
风中黎昕完成签到 ,获得积分10
11秒前
小粒橙完成签到 ,获得积分10
12秒前
BetterH完成签到 ,获得积分10
12秒前
linuo完成签到,获得积分10
13秒前
14秒前
wanci应助haha采纳,获得10
15秒前
16秒前
16秒前
张会发布了新的文献求助10
18秒前
18秒前
li12029完成签到 ,获得积分10
19秒前
LSYLIZ发布了新的文献求助10
20秒前
smm完成签到 ,获得积分10
20秒前
谦让水池发布了新的文献求助30
20秒前
靓丽的傲芙完成签到,获得积分10
21秒前
21秒前
22秒前
熬夜熊猫完成签到,获得积分10
23秒前
vkey完成签到,获得积分10
25秒前
斯文败类应助谦让水池采纳,获得10
28秒前
29秒前
31秒前
34秒前
个性大白发布了新的文献求助10
35秒前
hq完成签到,获得积分10
36秒前
39秒前
人间天堂发布了新的文献求助10
42秒前
42秒前
英姑应助LSYLIZ采纳,获得10
43秒前
Omni完成签到 ,获得积分10
44秒前
欢喜的祥发布了新的文献求助10
45秒前
谦让傲菡完成签到 ,获得积分10
45秒前
46秒前
今后应助小涵采纳,获得10
48秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Picture this! Including first nations fiction picture books in school library collections 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
ON THE THEORY OF BIRATIONAL BLOWING-UP 666
Signals, Systems, and Signal Processing 610
Chemistry and Physics of Carbon Volume 15 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6389009
求助须知:如何正确求助?哪些是违规求助? 8203354
关于积分的说明 17357998
捐赠科研通 5442572
什么是DOI,文献DOI怎么找? 2878011
邀请新用户注册赠送积分活动 1854352
关于科研通互助平台的介绍 1697897